Abstract

Moderated by: Charles Raison, M.D.

Researchers from different disciplines continue a debate whether “experience” and particularly the complex and evocative forms of experience in psychedelic states are necessary or crucial for therapeutic effects. The debate reaches far into the natural sciences and animal research, but it also poses philosophical questions related to our understanding of the scientific method and the forms of rigor that we can apply in psychedelic research. Can research on the molecular level and with laboratory animals tell us something about the importance of experience? How would psychosocial methodologies tackle the problem?  

Moderation and speakers in this panel could be changed until the last minute.